ÌÇÐÄÆƽâ°æ

Top 10 multiple sclerosis drugs worldwide by revenue in 2013 (in million U.S. dollars)

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

February 2014

Region

Worldwide, United States

Survey time period

2013

Supplementary notes

Statistic includes only FDA-approved drugs.
* Mostly U.S. sales.

Citation formats

Leading MS pharmaceutical drugs in the U.S. by revenue 2013

Published by ÌÇÐÄÆƽâ°æ Research Department, Dec 2, 2014
This statistic displays the top 10 multiple sclerosis FDA-approved drugs based on revenues globally in 2013. During this year, Tecfidera (dimethyl fumurate), sponsored and developed by Biogen Idec, generated *** million U.S. dollars in revenue. Tecfidera is used primarily for relapsing forms of MS. MS is a disease that damages nerve cells in the brain and spinal cord which disrupts the ability of the nervous system to communicate with the body.
Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Pharmaceutical market in the NetherlandsGlobal pharmaceutical industryHealth insurance in the NetherlandsPharmaceutical market in ItalyPharmaceutical industry in Sweden
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.